Myeloid Ezh2 Deficiency Limits Atherosclerosis Development
Macrophages define a key component of immune cells present in atherosclerotic lesions and are central regulators of the disease. Since epigenetic processes are important in controlling macrophage function, interfering with epigenetic pathways in macrophages might be a novel approach to combat athero...
Main Authors: | Annette E. Neele, Hung-Jen Chen, Marion J. J. Gijbels, Saskia van der Velden, Marten A. Hoeksema, Marieke C. S. Boshuizen, Jan Van den Bossche, Anton T. Tool, Hanke L. Matlung, Timo K. van den Berg, Esther Lutgens, Menno P. J. de Winther |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.594603/full |
Similar Items
-
Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice.
by: Sofia Xanthoulea, et al.
Published: (2009-01-01) -
Poorly Differentiated Breast Carcinoma is Associated with Increased Expression of the Human Polycomb Group EZH2 Gene
by: Frank M. Raaphorst, et al.
Published: (2003-11-01) -
Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages
by: Jan Van den Bossche, et al.
Published: (2016-10-01) -
Increased Expression of the EZH2 Polycomb Group Gene in BMI-1-Positive Neoplastic Cells during Bronchial Carcinogenesis
by: Roderick H.J. Breuer, et al.
Published: (2004-11-01) -
Distinct and separable roles for EZH2 in neurogenic astroglia
by: William W Hwang, et al.
Published: (2014-05-01)